Valeo Pharma Inc.Valeo Pharma Inc.Valeo Pharma Inc.

Valeo Pharma Inc.

No trades
See on Supercharts

VPHIF fundamentals

Valeo Pharma Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VPHIF for the last quarter is 10.07 M USD, and it's 6.64% higher compared to the previous quarter. The net income of Q1 24 is -5.11 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth